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Editor’s key points
† This study compared
blind intubation using
two supraglottic airway
devices (SADs) in patients
with anticipated difficult
airways.
† Intubation was
successful at the first
attempt in 69% of
patients using the
sILMATM tube through the
sILMATM.
† Success rate using a
Magill PVC tube through
the i-gelTM was very low
(15%).
† The difference between
SADs was related to the
SAD rather than the type
of tracheal tube used.
Background. The single-use supraglottic airway device i-gelTM has been described in several
case reports as a conduit for intubation, but no prospective data about success rates of
blind intubation are available. Therefore, we performed this prospective randomized
controlled trial to compare the success rate of blind tracheal intubation with a Magill PVC
tube through the i-gelTM with intubation using an sILMATM PVC tube through the single-
use intubating laryngeal mask airway (sILMATM).
Methods. With ethics committee approval and written informed consent, 80 patients with
predictors of a difficult airway were computer randomized to either supraglottic airway
device (SAD). The corresponding tracheal tube (TT) was introduced through the SAD
under fibreoptic visualization but without fibreoptic guidance. Primary outcome was blind
intubation success rate. Times, airway leak pressure, fibreoptic view, and adverse events
were recorded. To control for the influence of the TT, we compared data from 40 patients
described in an accompanying study (sILMATM with Magill TT and i-gelTM with sILMATM TT).
Results. Blind intubation success rate through the sILMATM (69%) was higher than with the
i-gelTM (15%, P,0.001). Data from the other patient group excluded the TT type as the
primary cause for the difference in success rate. Removal of SADs was without problems
with no difference between the type of SAD.
Conclusions. Blind tracheal intubation using the sILMATM tube through the sILMATM is much
more successful than blind intubation with a Magill PVC tube through the i-gelTM. Because of
its low success rate, we would not recommend blind intubation through the i-gelTM.
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The i-gelTM (Intersurgical Ltd, Wokingham, Berkshire, UK,
Figs 1B and 2) is a supraglottic airway device (SAD) that is
made of a thermoplastic elastomer (SEBS, styrene ethylene
butadiene styrene)1 and does not need an inflatable cuff to
provide the airway seal. The advantages are easy insertion
and possibly less tissue compression. Its easy placement
and sufficient seal pressure for clinical use has been well
documented.2 – 6 The large airway diameter of the i-gelTM
enables the introduction of a tracheal tube (TT) through
the i-gelTM.7 As fibreoptic bronchoscopes are not ubiquitously
available, clinicians might use the i-gelTM for blind tracheal
intubation in a cannot-intubate–cannot-ventilate scenario.
For this scenario, the Difficult Airway Society’s8 and the
American Society of Anesthesiologists’9 guidelines rec-
ommend an SAD, or more specifically, the intubating laryn-
geal mask airwayTM (ILMATM, The Laryngeal Mask Company
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Limited, Le Rocher, Victoria, Mahe´, Seychelles, Fig. 1A). The
ILMATM is a widely accepted and clinically investigated
device to facilitate intubation.10 11 The first-attempt
success rate for blind tracheal intubation through the
ILMATM is 80–87%11 12 and is improved with the use of a
fibrescope to 93%.12
Until now, there were only case reports, a study on
manikins,13 and one limited controlled trial evaluating the
clinical performance of blind intubation through the
i-gelTM.14 Therefore, we performed this prospective random-
ized controlled trial to evaluate the success rates of blind tra-
cheal intubation using a Magill PVC tube through the i-gelTM
with intubation using an sILMATM PVC tube through the
single-use intubating laryngeal mask airway (sILMATM).
Our hypothesis was that there would be a difference of
more than 30% in blind intubation success rates of the two
SADs and their corresponding tubes (i-gelTM with Magill PVC
tube or sILMATM with sILMATM tube).
Methods
Eighty patients were included after ethics committee
approval (Cantonal Ethics Committee Bern, Bern, Switzerland,
approval number 79/08, August 29, 2008, ClinicalTrials.gov
identifier: NCT00888875) and with patients’ written informed
consent. Inclusion criteria were American Society of
Anesthesiologists physical status I–IV, age 18–85 yr, under-
going elective surgery requiring tracheal intubation at the
University Hospital of Bern, and presenting at least one cri-
terion for predicted difficult airway management. We
defined independent risk factors for a difficult airway as
BMI .30 kg m22, thyromental distance ,6 cm, limited man-
dibular protrusion or retrognathia, abnormal neck anatomy,
modified Mallampati score .II,15 16 difficult intubation in
patient history, or mouth opening of ,3.5 cm.
Exclusion criteria were high risk of aspiration (non-fasted,
gastrooesophageal reflux disease), weight ,30 kg, known
difficult mask ventilation, mouth opening ,20 mm, oral car-
cinoma or bleeding that restricted the use of SADs, patients
who did not speak German, or declined to participate.
Patients were randomly assigned to two groups
(computer-generated randomization: www.randomization
.com) using sealed, opaque envelopes: Group 1, placement
of an i-gelTM and Magill PVC tube; and Group 2, placement
of an sILMATM and sILMATM tube.
Twenty-four staff anaesthetists with experience in the use
of both SADs and skilled in fibreoptic-guided tracheal intuba-
tion through SADs participated in this investigation. All par-
ticipants were under supervision by one of the main study
authors.
Premedication was with oral midazolam 7.5 mg 30 min
before induction of anaesthesia. Patients were asked to
remove dentures or a dental plate before anaesthesia.
A doughnut-shaped pillow was used to achieve optimal pos-
ition. Patients were monitored according to our standard
clinical operating procedures following the American
Society of Anesthesiologists’ recommendations.
Anaesthesia was induced using propofol 2% and fentanyl
2–3 mg kg-1, and maintained with i.v. propofol to keep BIS
40–60. No neuromuscular blocking drugs were given before
SAD insertion, which reflects the clinical practice of placing
SADs at our institution. After the insertion of the SAD and
completing all measurements, neuromuscular blocking
drugs were administered to decrease the incidence of cough-
ing during blind intubation and to reduce complications
during SAD removal.17
After loss of eye lash reflex, monitored, sufficient
bag-mask ventilation was performed (to maintain
SpO2.96% and normal capnography reading) and the lubri-
cated i-gelTM or sILMATM was introduced according to
randomization.
A
B
Fig 1 sILMA (TM) with sILMA TT (A) and the i-gel (TM) with Magill
PVC TT in place.
Tip of the fibreoptic scope proximal to the tip of the TT
Fig 2 i-gel with Magill PVC TT and fibreoptic scope in place. The
tip of the fibrescope is proximal to the tip of the TT allowing visu-
alised intubation technique without fibreoptic guidance.
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Insertion of the SAD
Selection of size and introducing technique were according to
the manufacturer’s recommendations: for the ILMATM,18 a
size 3 for 30–50 kg, a size 4 for 50–70 kg, and a size 5 for
more than 70 kg; for the i-gelTM,1 a size 3 for 30–50 kg (up
to 60 kg, if patient’s height was ,160 cm), a size 4 for
60–90 kg (down to 50 kg, if patient’s height was .160
cm), and a size 5 for more than 90 kg. This adaptation for
the i-gelTM for patients in the weight range 50–60 kg was
made to avoid the overlap between sizes 3 and 4. The cuff
of the ILMATM was fully deflated during insertion. For lubrica-
tion of the SADs, we used K-Y Lubricating Jelly (Johnson &
Johnson Medical Limited, Gargrave, Skipton, UK). Both SADs
were introduced as described by the manufacturers’ user
booklets1 18 without the help of another person. Once in
place, the cuff of the ILMATM was inflated to a maximum of
60 cm H2O,
19 using a manometer (VBM GmbH, Sulz,
Germany, or Ru¨sch GmbH, Kernen, Germany).
An initial assessment of ventilation was made by gently
squeezing the reservoir bag and observing end-tidal carbon
dioxide waveforms and chest movements.20 In the case of
adequate ventilation, leak pressure was measured as
described below. Adequate ventilation was defined as two
consecutive tidal volumes of at least 6 ml kg21 ideal body
weight (height in cm2100 in kg) during pressure-controlled
ventilation at 17 cm H2O applied by the anaesthetic
machine.21 22
When ventilation was not adequate, up to three minor
airway interventions could be performed (i.e. adjusting
head/neck position, changing depth of insertion).23 If the
first SAD failed after three attempts, the other SAD was
used, again allowing three manoeuvres.21
Time necessary for insertion was measured from the time
the face mask was taken away from the face until the
appearance of the CO2 trace on the capnograph.
Intubation
A fibrescope was primed with either a slightly curved lubri-
cated size 7.0 mm Magill PVC TT (Ru¨schTM Super Safety
Clear, Group 1, i-gelTM) or a lubricated reinforced 7.0 mm
sILMATM TT (Group 2, sILMATM) according to randomization.
After effective neuromuscular block was confirmed by loss
of twitch response, and after 2 min of oxygenation, the
breathing system was disconnected and the tube with the
fibrescope was introduced. The best fibreoptic view from
the outlet of the SAD on the glottis was graded from 1 to 4
(1, vocal cords entirely visible; 2, vocal cords or arytenoid
cartilages partially visible; 3, epiglottis only visible; 4, no
laryngeal structures visible).20
If possible, the TT was advanced through the glottic
opening under continuous visualization. Because the tip of
the fibrescope was proximal to the tip of the tube (Fig. 2),
there was no fibreoptic guidance possible, but advancement
of the tube could be stopped without applying force as soon
as the tube was seen to not freely enter the tracheal
opening. For patient safety reasons, we wanted to avoid
damage of the laryngeal structures. The fibrescope was not
manipulated during the blind insertion attempt. This pro-
cedure could be called ‘visualized blind technique’ or ‘tube
first fibreoptic technique’. The first attempt success rate of
blind tracheal intubation was our primary outcome
measure. The TT was fixed to the fibrescope in a way that
the tube’s tip pointed upwards, and the black writing on
the tube pointed to the back of the patient.12 14 Thus, the
TT followed the same course it would have followed with a
completely blind intubation. At the same time, the fibrescope
was not the leading part during tube advancement, but it
provided continuous visualization to instantly recognize
impossible intubation conditions and to prevent glottic struc-
ture damage.
In the case of failed first attempt of blind intubation, the
fibrescope was advanced beyond the tip of the tube and
was introduced into the trachea, and the TT was advanced
over the fibrescope as done by Joo and Rose.12 If fibreoptic
intubation failed as well, the other SAD was used, but the
success was not evaluated according to intention-to-treat
analysis. If the alternative SAD failed or if SpO2 decreased
to ,92% at any time, the SAD was abandoned and the
airway secured according to the anaesthetist’s decision.
After intubation, the fibrescope was removed and the
breathing circuit reconnected. Intubation time was
measured from the time the breathing circuit was discon-
nected until the carbon dioxide curve appeared on the
monitor.
During removal of the SAD, we carefully avoided acciden-
tal extubation. The ILMATM stabilizer rod was used for both
SADs, according to the ILMATM user booklet.18 Time to
remove the SAD was measured from disconnection of the
breathing system until reappearance of the carbon dioxide
curve on the monitor. At this time, the study was finished
and anaesthesia was maintained according to the
anaesthetist.
Airway leak pressure
Airway leak pressure was measured by closing the circle
system’s expiratory valve at a fixed gas flow of 3 litres
min21 and noting the airway pressure (max. allowed 40 cm
H2O) at which equilibrium was reached or audible air was
leaking.24 Air entering the stomach was detected by auscul-
tation over the epigastrium.21
Adverse events
During the study period, from starting anaesthesia until
discharge from the postoperative recovery unit, any adverse
events were recorded. Adverse events were defined as suspi-
cion of aspiration/regurgitation (gastric fluid in the venti-
lation tube or in the hypopharynx), hypoxia (SpO2 ,92%),
hypotension (mean arterial pressure ,55 mm Hg), hyperten-
sion (mean arterial pressure +20% over pre-induction base-
line), tachycardia and bradycardia (+20% of pre-induction
value), bronchospasm, airway obstruction, coughing, dental,
tongue, or lip trauma.
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Evaluation of postoperative complaints
A structured interview with the patient was performed 24
h after the operation to obtain data about adverse
effects.25 In the case of ambulatory surgery, we called
the patients by phone. The interviewer was not aware of
any problems encountered during insertion or surgery
and was blinded about randomization, and the perform-
ance of the SAD/TT. Items included sore throat, hoarse-
ness, dysphagia, postoperative nausea and vomiting,
rescue medication, pain, analgesics taken, and any
unscheduled re-hospitalization.
Comparison with patients from accompanying study
using alternative TT (i-gelTM with sILMATM TT;
sILMATM with Magill PVC TT)
In order to check if the difference in blind intubation success
rates was caused by the fact that we used two different TTs,
we compared the data from the 80 patients with those from
a similar group of patients described in an accompanying
study.26 These 40 patients were equally randomized to
either SAD but were intubated through the i-gelTM with the
sILMATM tube and through the sILMATM with the Magill PVC
tube. Again, the primary outcome was the success rate of
blind tracheal intubation.
Statistical analysis
On the basis of our experience with the i-gelTM, we expected
a difference of at least 30% in first-attempt success rates
(primary outcome measure) in favour of the sILMATM, and
we calculated our sample size according to these expec-
tations. Our null hypothesis was that the difference of first-
attempt blind intubation success rates between the two
SADs would be ,30%. Our alternative hypothesis was that
the difference of the success rates would be .30%. As first-
attempt success rates for blind tracheal intubation for the
ILMATM are 80–87%,11 12 76 patients would be necessary
with a given a of 0.05 and a b-value of 0.2 (Primer of Biosta-
tistics, V.4.02).
For our primary outcome variable, the success rate of the
first blind intubation attempt, and other frequency data, we
compared the values with x2 test. The devices were evalu-
ated as intention-to-treat according to randomization.
Continuous data were analysed with Student’s t-test if
normality distribution could be assumed; otherwise the
Mann–Whitney test was used.
To evaluate whether the SADs or the TTs were respon-
sible for the difference in success rate, we performed a
2×2 analysis of the intubation success (x2 test) after
having checked for patient characteristic differences. We
analysed all data with SPSS V.15 (SPSS Inc., Chicago, IL,
USA/SPSS Schweiz AG, Zu¨rich, Switzerland). Data are
presented as mean (standard deviations), and percentage.
A probability value of ,0.05 was considered statistically
significant.
Results
Participants and patient characteristics
We screened 912 patients undergoing general anaesthesia in
a time period of 8.5 months (total 265 days); 677 of them
required tracheal intubation (624 were adults). Inclusion cri-
teria were not fulfilled by 534 patients, leaving 90 patients
with predictors of a difficult airway eligible for the study.
Five patients did not give informed consent, and five others
were not randomized because of changes in surgical pro-
cedure. Therefore, we investigated 80 patients (Fig. 3).
Patients’ characteristics did not differ importantly
(Table 1). We investigated more males than females (64%
vs. 36%), but the ratio was equal in both SAD-groups. Fur-
thermore, there were no differences in characteristics
between the 80 patients and the 40 patients described in
the accompanying study.
Mask ventilation was deemed to be easy in 60 cases, in
the other 20 cases, either two-handed ventilation or a
Guedel Airway was necessary.
Insertion of the SADs
There was no difference in the insertion success rates
between i-gelTM and sILMATM (Table 2). In one case of a
failed i-gelTM insertion, the airway was rescued by oral intu-
bation. One sILMATM insertion failed because of inadequate
ventilation without hypoxia. This patient’s trachea was intu-
bated by fibreoptic guidance through an i-gelTM. One i-gelTM
had to be changed from size 4 to 5 in a male patient of
90 kg and 173 cm, although the size selection was according
to the manufacturer’s description.
There were no differences in first-attempt success rates of
SAD insertion, insertion time, airway leak pressure, and tidal
volumes (Table 2).
In the comparison group of 40 patients from the accom-
panying study,26 ventilation after SAD insertion was success-
ful in all i-gelTM patients, and in all but one sILMATM patient.
Blind tracheal intubation
Blind intubation success rate was significantly higher for the
sILMATM group (69%) compared with the i-gelTM group (15%,
P,0.001, Table 3). There was no difference in fibreoptic laryn-
geal view, epiglottic downfolding, and time necessary for
intubation (Table 3). Of the 12 patients who could not be
blindly intubated in the sILMATM group, 10 were intubated
by fibreoptic guidance and in two patients, conventional lar-
yngoscopy was necessary to finally secure the airway.
Of the 33 failed blind intubations in the i-gelTM group, 32
patients were intubated by fibreoptic-guided intubation and
one by conventional intubation. In that one case, intubation
through the i-gelTM was impossible because of an unusually
small glottic opening, and the patient was intubated orally
with a smaller size TT by the aid of a FrovaTM catheter
(Frova Intubating Introducers, CookTM Medical Ireland Ltd,
Limerick, Ireland). We found no significant difference for
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the successful fibreoptic intubation rate after a failed blind
intubation attempt between both SADs.
Blind intubation in the comparison group of 40 patients26
revealed a success rate of 21% for the sILMATM tube through
the i-gelTM and a success rate of 60% for the Magill PVC tube
through the sILMATM (P¼0.02). Because we found compar-
able patient characteristics, we performed a 2×2 analysis
of the insertion success rate. That confirmed a large differ-
ence for the SADs (P¼0.001 and 0.002), but not for the
tubes (P¼0.59 and 0.48, Table 4).
Removal of the SAD
All 78 inserted SADs were removed without complications
using the ILMATM exchange rod. There was no difference in
removal time between both SADs [44 (20) s for the i-gelTM
vs. 46 (20) s for the sILMATM, P¼0.59].
Haemodynamics, adverse events, and postoperative
complaints
There were no differences in haemodynamic changes during
insertion or intubation between the groups. One i-gelTM (3%)
and two sILMAsTM (5%) were stained with blood after
removal (P¼1.00).
In one patient, an i-gelTM failed and he desaturated below
90% before the intubation attempt. Conventional oral intu-
bation secured the airway without any problem. Also, one
patient with an sILMATM in place desaturated briefly below
90% during fibreoptically guided intubation. There were no
other adverse events.
There were no statistically significant differences in post-
operative complaints between the groups; sore throat
occurred in 25% (i-gelTM) vs. 8% (sILMATM), P¼0.08.
Discussion
In this study, the success rate of blind intubation through the
i-gelTM using a Magill PVC TT was significantly lower com-
pared with the sILMATM using the sILMATM TT. This did not
change if we used the other tube (i-gelTM with the sILMATM
tube, and sILMATM with the Magill PVC tube).
The airway outlet of the i-gelTM is large, and provides a
good view of the vocal cords. Epiglottic downfolding is rare
Screened patients undergoing
general anaesthesia: 912
Surgeries for adult patients
requiring intubation: 624
Given informed consent: 85
Randomized: 80
Refused to participate: 5 Exclusion criteria: 534
Not randomized: 5
(surgical procedure changed)
33 not successful, solution:
32x fibreoptic intubation via i-gel
1 x direct laryngoscopy
i-gel removal possible: 39 sILMA removal possible: 39
12 not successful, solution:
10x fibreoptic intubations via sILMA
2x direct laryngoscopy
Successful blind intubation
via i-gel: 6
Successful blind intubation
via sILMA: 27
1 i-gel failure
Solution: direct laryngoscopy
Insertion of i-gel: 40
Succees: 39
Insertion of sILMA: 40
Succees: 39
1 sILMA failure 
Solution: i-gel
Fig 3 Study Flowchart.
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which favours a successful intubation. However, in relation to
the laryngeal structures, the airway outlet of the i-gelTM
seems to provide an unfavourable angle. When the TT exits
the i-gelTM, it often gets caught in the arytenoid cartilage
or other posterior structures of the larynx. In order to enter
the trachea, fibrescope and tube often need to be pushed
anterior. This might be improved by reshaping the airway
outlet of the i-gelTM to optimize the angle.
Compared with the success rate of the sILMATM with the
sILMATM tube (69%), the i-gelTM with the Magill PVC tube
had a success rate of only 15%, clearly favouring airway
management using the sILMATM with the sILMATM tube.
The success rate of blind intubation at the first attempt
with the sILMATM was only 69%. This is similar to a study
published earlier comparing ILMATM and sILMATM,27 but
lower than expected from larger studies.11 12 This may
be a consequence of the selected patient population with
predictors of difficult airway management. In addition,
we performed the so-called blind intubation attempt
without fibreoptic guidance, but under visual control with
the scope. Therefore, whenever the TT experienced resist-
ance from the posterior (or anterior) part of the larynx,
the tube was not forced in any direction in order to
prevent tissue damage. The success rate may have been
higher without a visual control because one might tend
to try to overcome the resistance. We only looked at first
blind intubation success rate and did not allow airway
manoeuvres known to facilitate blind intubation
success.18 The main purpose of the present study was to
compare two different airway sets rather than determining
the influence of different TTs. The success rate of blind
intubation through the i-gelTM might be improved by
using a different TT instead of the Magill PVC tube that
was used in the current study. However, the results from
our comparison group of 40 patients from the accompany-
ing study26 showed that the difference in success rates
was rather attributed to the different SADs than to the
different TTs (Table 4). The two different TTs did not
cause the large difference in blind intubation success
Table 1 Patient characteristics and perioperative results. Data
shown as mean (range) or number (%). BMI, body mass index; TM,
thyroid-mental distance
i-gel sILMA
Patients, n (%) 40 (50) 40 (50)
Age (yr) mean (range) 57 (24-84) 55 (21-81)
Women, n (%) 16 (40) 13 (33)
ASA I–IV, n (%) 1/27/12/0
(3/68/30/0)
7/23/9/1
(18/58/23/3)
Height (m) 1.72 (0.10) 1.73 (0.1)
Weight (kg) 84 (22) 87 (18)
BMI (kg m22) 28 (6) 29 (4)
BMI.30 kg m22, n (%) 18 (45) 18 (45)
TM,6 cm, n (%) 3 (08) 4 (10)
No jaw protrusion, n (%) 4 (10) 4 (10)
Sleep apnoea, n (%) 9 (23) 13 (33)
Mallampati score 1–3, n (%) 13/18/9
(33/45/23)
12/11/17
(30/28/43)
Mouth opening ,3.5 cm, n (%) 9 (23) 5 (13)
Mask ventilation possible
without help, n (%)
32 (80) 28 (70)
Mask ventilation only possible
with help, n (%)
8 (20) 12 (30)
Duration of surgery (min) 136 (91) 153 (104)
Duration of anaesthesia (min) 223 (122) 245 (121)
Table 3 Intubation through the supraglottic airway devices.
Statistically significant differences between the groups are
indicated (*). Data presented as mean (SD) or number (%).
*P,0.001; †Laryngeal view was graded from 1 to 4 (1, vocal cords
entirely visible; 2, vocal cords or arytenoid cartilages partially
visible; 3, epiglottis only visible; 4, no laryngeal structures
visible)20
i-gelTM
(n539)
sILMATM
(n539)
Blind intubation successful, n (%) 6 (15) 27 (69)*
Laryngeal view†, n (%) 25/7/3/4
(64/18/8/10)
20/13/2/4
(51/33/5/10)
Epiglottic downfolding, n (%) 4 (10) 2 (5)
Time for blind intubation (s) 45 (14) 44 (22)
Table 4 Difference in success rates of blind intubation because of
supraglottic airway device or tube? 2×2 table comparing i-gelTM
and sILMATM with either the sILMATM tracheal tube or the Ru¨schTM
Magill PVC tracheal tube. Numbers are given in number (%) of
blind intubation success. P-values of the columns are not
significant (0.59, 0.48), P-values of the rows are ,0,001. As the
comparison group, data were used from a group of patients
further described in an accompanying study (see text)26
i-gelTM n558 sILMATM n559
Tracheal tube
Magill PVC tube (n¼59) 6 (15) 12 (60)
sILMATM tube (n¼58) 4 (21) 27 (69)
P-value 0.59 0.48
Table 2 SAD insertion. No statistically significant differences were
found. Data shown as mean (SD) or number (%)
i-gelTM
(n540)
sILMATM
(n540)
Success at first attempt, n (%) 36 (90) 38 (95)
Overall success, n (%) 39 (98) 39 (98)
Minor intervention necessary, n (%) 11 (28) 8 (20)
Time to supraglottic airway device
insertion (s)
33 (18) 36 (20)
Tidal volume (ml) 587 (164) 557 (154)
Airway leak pressure (cm H2O) 26 (8) 30 (7)
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rate, but we were unable to quantify their influence on our
primary outcome measure.
The sizes of the SADs were chosen according to the man-
ufacturer’s handbook; one i-gelTM had to be changed from
size 4 to size 5 to obtain adequate seal. Two other i-gelsTM
had to be changed from size 4 to size 3. This reflects the
ongoing discussion about SADs: size selection should also
include patient characteristics such as height,28 and
perhaps even age and gender.29
Limitations of the study
We recognize some limitations to this study. First, we com-
pared visualized blind intubation through SADs (‘tube first
fibreoptic technique’). We did not compare true blind
intubation, where sometimes intubation is accomplished by
overcoming resistance with light force. Instead, TT advance-
ment was closely monitored in order to avoid damage of any
laryngeal structures. The tip of the fibreoptic bronchoscope
always remained proximal to the tip of the TT. There was
no guidance or manipulation of the fibrescope, and the
tube’s path was the same as in a blind intubation attempt,
mimicking clinical practice.
Secondly, we included patients with predictors of difficult
airway management. All predictors of difficult mask venti-
lation, difficult laryngoscopy, and difficult intubation quali-
fied as inclusion criteria. Because of ethical considerations,
we did not include patients with a history of difficult airway
in this study, denying them the advantage of an awake
fibreoptic intubation. Thirdly, we used the i-gelTM with a
Magill PVC TT and compared this with the sILMATM with its
sILMATM tube. The sILMATM TT is specifically designed for
blind intubation. By doing so, we did not only compare the
SAD, but an airway set. We decided to use an everyday PVC
TT for the i-gelTM and not the sILMATM tube because in
case of a cannot–ventilate–cannot–intubate situation, clin-
icians initially have to fall back on devices they have readily
available in the operating theatre. That is, an SAD (e.g. the
i-gelTM) to re-establish ventilation which might be followed
by intubation. Therefore, the clinician must know if a
commonly used PVC tube is useful for blind airway rescue
procedures. Fourthly, we compared the data from the
80 patients with data from a group of 40 patients described
in another study.26 These 40 patients were included in two
studies, although different outcome measures were evalu-
ated. The inclusion of these 40 patients is not a fully random-
ized 2×2 factorial analysis. We decided to include this group
for comparison after analysis of the 80 patients described, in
order to check if the difference in success rate was mainly
attributable to the two different TTs.30 The two patient popu-
lations showed no characteristic differences, they were col-
lected with the same inclusion and exclusion criteria, and
they were fully randomized. With a high probability, the
SADs are largely responsible for the difference in success
rates for blind intubation, and not the TTs. Finally, the
study personnel were not all experts in the field of airway
management; however, all 24 participating anaesthetists
were experienced in the use of both SADs and fibreoptic intu-
bation through SADs, and they were under supervision by one
of the main study authors. Our results reflect true clinical
performance of the devices in a daily clinical anaesthetic
setting. Failures were evenly distributed among investigators.
We also found no difference between the participating
anaesthetists regarding intubation time.
In conclusion, we found that blind tracheal intubation
through the i-gelTM using a PVC TT was substantially inferior
compared with intubation through the sILMATM using the
sILMATM TT in patients with predictors of difficult airway
management under general anaesthesia. Therefore, we do
not recommend blind intubation through the i-gelTM. The
sILMATM tube does not substantially improve blind intubation
success with the i-gelTM as conduit. When blind intubation
failed, fibreoptically guided intubation through the i-gelTM
was highly successful.
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